The androgen receptor - a protein ignition switch for prostate cancer cell growth and division - is a master of adaptability. When drug therapy deprives the receptor of androgen hormones, thereby halting cell proliferation, the receptor manages to find an alternate growth route. A new study by Dana-Farber Cancer Institute and Ohio State University scientists demonstrates how.
Full article >>
Monday, July 27, 2009
Study reveals a reprogrammed role for the androgen receptor
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment